Laddar...
CSF beta-amyloid 1–42 – what are we measuring in Alzheimer's disease?
OBJECTIVE: To characterize biological and technical factors which influence cerebrospinal fluid (CSF) Alzheimer's disease (AD) biomarker levels, including the presence of apolipoprotein E (APOE) ε4 allele, AD diagnosis, Aβ-binding proteins, sample processing, and preanalytical handling. METHODS...
Sparad:
| I publikationen: | Ann Clin Transl Neurol |
|---|---|
| Huvudupphovsmän: | , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BlackWell Publishing Ltd
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4338954/ https://ncbi.nlm.nih.gov/pubmed/25750918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.160 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|